How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia?

Table 3 Comparison of non-advanced adenoma and colorectal neoplasia in the target and control groups

	Target group (n = 726)	Control group (n = 774)	OR, 95%CI (P value)1
Adenoma, n	346	270	1.2, 0.9-1.5
(%, 95%CI)	(48%, 44%-51%)	(35%, 32%-38%)	(0.18)
Advanced adenoma, n	131	66	1.8, 1.2-2.5
(%, 95%CI)	(18%, 15%-21%)	(9%, 7%-11%)	(< 0.01)
Cancer, n	11	11	0.7, 0.3-1.6
(%, 95%CI)	(2%, 1%-3%)	(1%, 1%-3%)	(0.35)

¹Adjusted comparison by logistic regression - including age, sex and previous FIT+ (fecal immunochemical test positivity).